ISB News

Earth To Dinner 2 at Seattle Culinary Academy

ISB participated in Earth To Dinner 2 on Jan. 12 at Seattle Culinary Academy. This was a follow-up event for the Dec. 12 Earth to Dinner event at ISB. (Read more…)

The theme was sustainable food/agriculture and urban design. Panelists for the evening included:

Grace Kim: Architect and co-founder of Schemata Workshop
Liz Fikejs: Conservation Program Manager, Seattle Public Utilities
Jessica Day: Project Manager, Project Feed 1010
Dean DeCrease: Principal of Festivore Design Works and Chief Governing Officer & Board Chair, Central Co-Op
Julia Sanders: Deputy Director, Global Ocean Health

Watch the Facebook Live video:

About Earth To Dinner: In December 2015, 195 global leaders came together to adopt the historic Paris Agreement – the world’s first comprehensive climate agreement. GOOD, in partnership with the #EarthTo coalition (100+ partners strong), has created the #EarthToDinner (earthtodinner.org) climate conversation dinner series to keep climate action on the table.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.